Abstract
Glucagon-like peptide-1 (GLP-1) receptor agonists as a new treatment option for hypothalamic obesity in the paediatric population: Preliminary data from a tertiary paediatric endocrine centre
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have